These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 211144)

  • 1. Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders.
    Mbaga DS; Kenmoe S; Kengne-Ndé C; Ebogo-Belobo JT; Mahamat G; Foe-Essomba JR; Amougou-Atsama M; Tchatchouang S; Nyebe I; Feudjio AF; Kame-Ngasse GI; Magoudjou-Pekam JN; Fokou LKM; Meta-Djomsi D; Maïdadi-Foudi M; Touangnou-Chamda SA; Daha-Tchoffo AG; Selly-Ngaloumo AA; Nayang-Mundo RA; Yéngué JF; Taya-Fokou JB; Kenfack-Momo R; Atembeh Noura E; Demeni Emoh CP; Tazokong HR; Bowo-Ngandji A; Sake CS; Atenguena Okobalemba E; Njiki Bikoi J; Njouom R; Riwom Essama SH
    PLoS One; 2022; 17(1):e0262903. PubMed ID: 35061846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and significance of hepatitis B and A virus serologic markers in Greek cirrhotic patients.
    Theodoropoulos G; Hadzis G
    Gastroenterol Jpn; 1985 Oct; 20(5):436-40. PubMed ID: 4076727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune response induced by hepatitis B virus principal antigens.
    Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
    Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis-associated antigen: clinical and immunological significance].
    Berg PA
    Klin Wochenschr; 1972 Feb; 50(3):125-38. PubMed ID: 4335527
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence and significance of hepatitis B e antigen and antibody in postnecrotic cirrhosis and primary hepatocellular carcinoma.
    Coursaget P; Maupas P; Goudeau A; Drucker J
    J Clin Microbiol; 1978 Apr; 7(4):394-5. PubMed ID: 211144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
    Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
    Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
    Liaw YF; Chu CM; Lin DY; Sheen IS; Yang CY; Huang MJ
    J Med Virol; 1984; 13(4):385-91. PubMed ID: 6330293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus and primary liver carcinoma: evidences for a filiation hepatitis B, cirrhosis and primary liver cancer.
    Maupas P; Coursaget P; Goudeau A; Drucker J; Sankale M; Linhard J; Diebolt G
    Ann Microbiol (Paris); 1977; 128(2):245-53. PubMed ID: 71006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma.
    Karayiannis P; Fowler MJ; Lok AS; Greenfield C; Monjardino J; Thomas HC
    J Hepatol; 1985; 1(2):99-106. PubMed ID: 2997321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma.
    Vogel CL; Anthony PP; Mody N; Barker LF
    Lancet; 1970 Sep; 2(7674):621-4. PubMed ID: 4195767
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme.
    Nielsen JO; Dietrichson O; Juhl E
    Lancet; 1974 Oct; 2(7886):913-5. PubMed ID: 4138200
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody to hepatitis-B-virus core in man.
    Hoofnagle JH; Gerety RJ; Barker LF
    Lancet; 1973 Oct; 2(7834):869-73. PubMed ID: 4126916
    [No Abstract]   [Full Text] [Related]  

  • 14. New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.
    Magnius LO; Espmark JA
    J Immunol; 1972 Nov; 109(5):1017-21. PubMed ID: 4116763
    [No Abstract]   [Full Text] [Related]  

  • 15. Dane particles, DNA polymerase, and e-antigen in two different categories of hepatitis B antigen carriers.
    Nordenfelt E; Kjellén L
    Intervirology; 1975; 5(3-4):225-32. PubMed ID: 1193824
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.